Das maligne Lymphom des Hundes

I. Zenker; J. Hirschberger

doi:10.1055/s-0038-1622612

Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere, Table of Contents

Tierarztl Prax Ausg K Kleintiere Heimtiere 2007; 35(02): 141-147
DOI: 10.1055/s-0038-1622612

Für Studium und Praxis

Schattauer GmbH

Das maligne Lymphom des Hundes

Übersicht und neue Therapieansätze

Authors

I. Zenker

¹Abteilung für Onkologie der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
J. Hirschberger

¹Abteilung für Onkologie der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München

Abstract

Full Text

References

Literaturf
1 Blackwood L, Sullivan M, Lawson H. Radiographic abnormalities in canine multicentric lymphoma: a review of 84 cases. J Small Anim Pract 1997; 38 (02) 62-69.
2 Carlo GL, Cole P, Miller AB, Munro IC, Solomon KR, Squire RA. Review of a study reporting an association between 2,4-dichlorophenoxyacetic acid and canine malignant lymphoma: report of an expert panel. Regul Toxicol Pharmacol 1992; 16 (03) 245-252.
3 Chun R, Garrett LD, Vail DM. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2000; 14 (02) 120-124.
4 Dobson JM, Samuel S, Milstein H, Rogers K, Wood JL. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J SmallAnim Pract 2002; 43 (06) 240-246.
5 Dorn CR, Taylor DO, Schneider R. The epidemiology of canine leukemia and lymphoma. Bibl Haematol 1970; (36) 403-415.
6 Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002; 16 (06) 704-709.
7 Hayes HM, Tarone RE, Cantor KP, Jessen CR, McCurnin DM, Richardson RC. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst 1991; 83 (17) 1226-1231.
8 Kessler M. Kleintieronkologie: Diagnose und Therapie von Tumorerkrankungen bei Hunden und Katzen, 2. Aufl. Stuttgart: Parey; 2005
9 Laing EJ, Fitzpatrick PJ, Binnington AG, Norris AM, Mosseri A, Rider WD. et al Half-body radiotherapy in the treatment of canine lymphoma. J Vet Intern Med 1989; 3 (02) 102-108.
10 Moore AS, London CA, Wood CA, Williams LE, Cotter SML, Heureux DA. et al Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999; 13 (05) 395-398.
11 Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA. et al Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001; 15 (04) 348-354.
12 Moore PF, Olivry T, Naydan D. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells. Am J Pathol 1994; 144 (02) 421-429.
13 Morrison W. Cancer in Dogs and Cats: Medical and Surgical Management. 2nd ed.. Jackson, WY: Teton New Media; 2002
14 Myers NC, Moore AS, Rand WM, Gliatto J, Cotter SM. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Intern Med 1997; 11 (06) 333-339.
15 Ogilvie GK, Fettman MJ, Mallinckrodt CH, Walton JA, Hansen RA, Davenport DJ. et al Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Cancer 2000; 88 (08) 1916-1928.
16 Raskin RE, Krehbiel JD. Prevalence of leukemic blood and bone marrow in dogs with multicentric lymphoma. J Am Vet Med Assoc 1989; 194 (10) 1427-1429.
17 Rassnick KM, Mauldin GE, Al-Sarraf R, Mauldin GN, Moore AS, Mooney SC. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989–2000). J Vet Intern Med 2002; 16 (05) 576-580.
18 Rosenberg MP, Matus RE, Patnaik AK. Prognostic factors in dogs with lymphoma and associated hypercalcemia. J Vet Intern Med 1991; 5 (05) 268-271.
19 Siedlecki CT, Kass PH, Jakubiak MJ, Dank G, Lyons J, Kent MS. Evaluation of an actinomycin- D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. Can Vet J 2006; 47 (01) 52-59.
20 Simon D, Nolte I, Eberle N, Abbrederis N, Killich M, Hirschberger J. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. J Vet Intern Med 2006; 20 (04) 948-954.
21 Starrak GS, Berry CR, Page RL, Johnson JL, Thrall DE. Correlation between thoracic radiographic changes and remission/survival duration in 270 dogs with lymphosarcoma. Vet Radiol Ultrasound 1997; 38 (06) 411-418.
22 Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K. et al CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med 2006; 20 (01) 136-143.
23 Zenker I. Allgemeine Aspekte der Chemotherapie in der kleintierpraxis. Tierärztl Prax 2005; 33 (K) 384-388.